Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Longitudinal trajectory of fatigue with initiation of biologic therapy in inflammatory bowel diseases: A prospective cohort study.

Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van der Woude CJ, Ananthakrishnan AN.

J Crohns Colitis. 2019 Aug 26. pii: jjz148. doi: 10.1093/ecco-jcc/jjz148. [Epub ahead of print]

PMID:
31504365
2.

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis.

Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB.

Crohns Colitis 360. 2019 Jul;1(2):otz009. doi: 10.1093/crocol/otz009. Epub 2019 Jun 7.

3.

Use of narrative concepts in the EHR to validate genetic determinants of treatment response in a virtual inflammatory bowel disease cohort.

Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Savova G, Shaw SY, Churchill S, Burke KE, Karlson EW, Murphy SN, Kohane I, Liao KP, Xavier RJ.

Clin Gastroenterol Hepatol. 2019 Aug 9. pii: S1542-3565(19)30861-4. doi: 10.1016/j.cgh.2019.08.005. [Epub ahead of print] No abstract available.

PMID:
31404664
4.

Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.

Burke KE, Nayor J, Campbell EJ, Ananthakrishnan AN, Khalili H, Richter JM.

Dig Dis Sci. 2019 Aug 1. doi: 10.1007/s10620-019-05754-9. [Epub ahead of print]

PMID:
31367882
5.

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.

Smillie CS, Biton M, Ordovas-Montanes J, Sullivan KM, Burgin G, Graham DB, Herbst RH, Rogel N, Slyper M, Waldman J, Sud M, Andrews E, Velonias G, Haber AL, Jagadeesh K, Vickovic S, Yao J, Stevens C, Dionne D, Nguyen LT, Villani AC, Hofree M, Creasey EA, Huang H, Rozenblatt-Rosen O, Garber JJ, Khalili H, Desch AN, Daly MJ, Ananthakrishnan AN, Shalek AK, Xavier RJ, Regev A.

Cell. 2019 Jul 25;178(3):714-730.e22. doi: 10.1016/j.cell.2019.06.029.

PMID:
31348891
6.

Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.

Faye AS, Wen T, Ananthakrishnan AN, Lichtiger S, Kaplan GG, Friedman AM, Lawlor G, Wright JD, Attenello FJ, Mack WJ, Lebwohl B.

Clin Gastroenterol Hepatol. 2019 Jul 20. pii: S1542-3565(19)30772-4. doi: 10.1016/j.cgh.2019.07.028. [Epub ahead of print]

PMID:
31336196
7.

Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study.

Sheriff MZ, Mansoor E, Luther J, Ananthakrishnan AN, Abou Saleh M, Ho E, Briggs FBS, Dave M.

Inflamm Bowel Dis. 2019 Jul 17. pii: izz147. doi: 10.1093/ibd/izz147. [Epub ahead of print]

PMID:
31314891
8.

Ulcerative Colitis and Crohn's Disease Have the Same Burden and Goals for Treatment.

Le Berre C, Ananthakrishnan AN, Danese S, Singh S, Peyrin-Biroulet L.

Clin Gastroenterol Hepatol. 2019 Jul 10. pii: S1542-3565(19)30738-4. doi: 10.1016/j.cgh.2019.07.005. [Epub ahead of print] Review.

PMID:
31301452
9.

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.

Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ, Casero D, Courtney H, Gonzalez A, Graeber TG, Hall AB, Lake K, Landers CJ, Mallick H, Plichta DR, Prasad M, Rahnavard G, Sauk J, Shungin D, Vázquez-Baeza Y, White RA 3rd; IBDMDB Investigators, Braun J, Denson LA, Jansson JK, Knight R, Kugathasan S, McGovern DPB, Petrosino JF, Stappenbeck TS, Winter HS, Clish CB, Franzosa EA, Vlamakis H, Xavier RJ, Huttenhower C.

Nature. 2019 May;569(7758):655-662. doi: 10.1038/s41586-019-1237-9. Epub 2019 May 29.

PMID:
31142855
10.

Association Between Vulvovaginal Discomfort and Activity of Inflammatory Bowel Diseases.

Ona S, James K, Ananthakrishnan AN, Long MD, Martin C, Chen W, Mitchell CM.

Clin Gastroenterol Hepatol. 2019 May 18. pii: S1542-3565(19)30528-2. doi: 10.1016/j.cgh.2019.05.018. [Epub ahead of print]

PMID:
31108226
11.

Correction: Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women Without Celiac Disease: A Prospective Cohort Study.

Liu PH, Lebwohl B, Burke KE, Ivey KL, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

Am J Gastroenterol. 2019 May;114(5):837. doi: 10.14309/ajg.0000000000000211. No abstract available.

PMID:
31082842
12.

The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel Diseases.

Deepak P, Axelrad JE, Ananthakrishnan AN.

Gastrointest Endosc Clin N Am. 2019 Jul;29(3):447-470. doi: 10.1016/j.giec.2019.02.006. Epub 2019 Apr 5. Review.

PMID:
31078247
13.

Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease.

Nazarenkov N, Seeger K, Beeken L, Ananthakrishnan AN, Khalili H, Lewis JD, Konijeti GG.

Gastroenterol Hepatol (N Y). 2019 Mar;15(3):133-144.

14.

Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease.

Vedamurthy A, Ananthakrishnan AN.

Gastroenterol Hepatol (N Y). 2019 Feb;15(2):72-82.

15.

Reply.

Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1919. doi: 10.1016/j.cgh.2019.04.007. Epub 2019 Apr 6. No abstract available.

PMID:
30965106
16.

Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases.

Borren NZ, Luther J, Colizzo FP, Garber JG, Khalili H, Ananthakrishnan AN.

J Crohns Colitis. 2019 Aug 14;13(8):990-995. doi: 10.1093/ecco-jcc/jjz020.

PMID:
30888405
17.

ACG Clinical Guideline: Ulcerative Colitis in Adults.

Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD.

Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.

PMID:
30840605
18.

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.

Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM, Cole AT, Cummings FR, Daly MJ, Ellul P, Fedorak RN, Festen EAM, Florin TH, Gaya DR, Halfvarson J, Hart AL, Heerasing NM, Hendy P, Irving PM, Jones SE, Koskela J, Lindsay JO, Mansfield JC, McGovern D, Parkes M, Pollok RCG, Ramakrishnan S, Rampton DS, Rivas MA, Russell RK, Schultz M, Sebastian S, Seksik P, Singh A, So K, Sokol H, Subramaniam K, Todd A, Annese V, Weersma RK, Xavier R, Ward R, Weedon MN, Goodhand JR, Kennedy NA, Ahmad T; IBD Pharmacogenetics Study Group.

JAMA. 2019 Feb 26;321(8):773-785. doi: 10.1001/jama.2019.0709. Erratum in: JAMA. 2019 Apr 23;321(16):1636.

19.

CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis Patients.

Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN.

Dig Dis Sci. 2019 Aug;64(8):2265-2272. doi: 10.1007/s10620-019-05520-x. Epub 2019 Feb 22.

PMID:
30796684
20.

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study.

Adar T, Faleck D, Sasidharan S, Cushing K, Borren NZ, Nalagatla N, Ungaro R, Sy W, Owen SC, Patel A, Cohen BL, Ananthakrishnan AN.

Aliment Pharmacol Ther. 2019 Apr;49(7):873-879. doi: 10.1111/apt.15177. Epub 2019 Feb 17.

PMID:
30773667
21.

Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis.

Kelly CR, Ananthakrishnan AN.

JAMA. 2019 Jan 15;321(2):151-152. doi: 10.1001/jama.2018.20397. No abstract available.

PMID:
30644970
22.

Tofacitinib: A Jak of All Trades.

Burke KE, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1438-1440. doi: 10.1016/j.cgh.2018.12.044. Epub 2019 Jan 6. No abstract available.

PMID:
30625401
23.

Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.

Borren NZ, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1736-1743.e4. doi: 10.1016/j.cgh.2018.12.032. Epub 2019 Jan 4. Review.

PMID:
30616024
24.

Cancer risk in microscopic colitis: a retrospective cohort study.

Levy A, Borren NZ, Maxner B, Tan W, Bellavance D, Staller K, Chung D, Khalili H, Ananthakrishnan AN.

BMC Gastroenterol. 2019 Jan 5;19(1):1. doi: 10.1186/s12876-018-0926-4.

25.

Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis.

Lee GC, Deery SE, Kunitake H, Hicks CW, Olariu AG, Savitt LR, Ananthakrishnan AN, Ricciardi R, Hodin RA, Bordeianou LG.

Int J Colorectal Dis. 2019 Mar;34(3):491-499. doi: 10.1007/s00384-018-03221-x. Epub 2019 Jan 4.

PMID:
30610435
26.

Fatigue in IBD: epidemiology, pathophysiology and management.

Borren NZ, van der Woude CJ, Ananthakrishnan AN.

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):247-259. doi: 10.1038/s41575-018-0091-9. Review.

PMID:
30531816
27.

Obesity and Weight Gain Since Early Adulthood Are Associated With a Lower Risk of Microscopic Colitis.

Liu PH, Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

Clin Gastroenterol Hepatol. 2018 Dec 6. pii: S1542-3565(18)31334-X. doi: 10.1016/j.cgh.2018.11.057. [Epub ahead of print]

PMID:
30529732
28.

Patient age determines adherence to preventive care measures among patients with ulcerative colitis.

Ghorbani S, Chandradas S, Wayman C, Diamant J, Ananthakrishnan AN, Konijeti GG.

Dig Liver Dis. 2019 Jan;51(1):178-179. doi: 10.1016/j.dld.2018.10.020. Epub 2018 Nov 6. No abstract available.

PMID:
30503295
29.

New approaches along the IBD course: diet, tight control and stem cells.

Ng SC, Ananthakrishnan AN.

Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):82-84. doi: 10.1038/s41575-018-0088-4. Review. No abstract available.

PMID:
30464302
30.

The Gut Microbiome and Digestive Health - A New Frontier.

Ananthakrishnan AN, Singal AG, Chang L.

Clin Gastroenterol Hepatol. 2019 Jan;17(2):215-217. doi: 10.1016/j.cgh.2018.10.040. Epub 2018 Oct 29. No abstract available.

PMID:
30385328
31.

The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children.

Lindoso L, Mondal K, Venkateswaran S, Somineni HK, Ballengee C, Walters TD, Griffiths A, Noe JD, Crandall W, Snapper S, Rabizadeh S, Rosh JR, LeLeiko N, Guthery S, Mack D, Kellermayer R, Gulati AS, Pfefferkorn MD, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley A, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Stephens MC, Baldassano R, Dubinsky MC, Markowitz J, Denson LA, Hyams J, Kugathasan S, Ananthakrishnan AN.

Am J Gastroenterol. 2018 Oct;113(10):1524-1529. doi: 10.1038/s41395-018-0239-9. Epub 2018 Sep 28.

PMID:
30267029
32.

Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.

Borren NZ, Khalili H, Luther J, Colizzo FP, Garber JJ, Ananthakrishnan AN.

Inflamm Bowel Dis. 2019 Mar 14;25(4):750-755. doi: 10.1093/ibd/izy282.

PMID:
30204864
33.

Debate session: So what causes inflammatory bowel disease? It's all in the environment.

Ananthakrishnan AN.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:24. doi: 10.1111/jgh.14429. No abstract available.

PMID:
30187567
34.

Bugs and drugs: Predicting response to therapy.

Ananthakrishnan AN.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:27. doi: 10.1111/jgh.14432. No abstract available.

PMID:
30187562
35.

Making sense of clinical predictors.

Ananthakrishnan AN.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:7-8. doi: 10.1111/jgh.14417. No abstract available.

PMID:
30187548
36.

Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study.

Liu PH, Lebwohl B, Burke KE, Ivey KL, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

Am J Gastroenterol. 2019 Jan;114(1):127-134. doi: 10.1038/s41395-018-0267-5.

PMID:
30181535
37.

Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Burke KE, Ananthakrishnan AN, Lochhead P, Liu PH, Olen O, Ludvigsson JF, Richter JM, Tworoger SS, Chan AT, Khalili H.

Gastroenterology. 2018 Dec;155(6):1764-1775.e2. doi: 10.1053/j.gastro.2018.08.029. Epub 2018 Aug 23.

PMID:
30144433
38.

Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.

Vedamurthy A, Xu L, Luther J, Colizzo F, Garber JJ, Khalili H, Ananthakrishnan AN.

Dig Dis Sci. 2018 Oct;63(10):2740-2746. doi: 10.1007/s10620-018-5176-3. Epub 2018 Jun 27.

PMID:
29951797
39.

Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.

Nalagatla N, Falloon K, Tran G, Borren NZ, Avalos D, Luther J, Colizzo F, Garber J, Khalili H, Melia J, Bohm M, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):502-509.e1. doi: 10.1016/j.cgh.2018.06.031. Epub 2018 Jun 23.

PMID:
29944926
40.

Reply to 'Comment on Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients'.

Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN.

J Crohns Colitis. 2018 Nov 9;12(10):1256. doi: 10.1093/ecco-jcc/jjy095. No abstract available.

PMID:
29939235
41.

Reply.

Ananthakrishnan AN, Ng SC.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1177. doi: 10.1016/j.cgh.2018.03.015. No abstract available.

PMID:
29914642
42.

Asians have more perianal Crohn disease and ocular manifestations compared with white Americans.

Kochar B, Barnes EL, Herfarth HH, Martin CF, Ananthakrishnan AN, McGovern D, Long M, Sandler RS.

Inflamm Intest Dis. 2018 Mar;2(3):147-153. doi: 10.1159/000484347. Epub 2017 Nov 18.

43.

The Association Between Arthralgia and Vedolizumab Using Natural Language Processing.

Cai T, Lin TC, Bond A, Huang J, Kane-Wanger G, Cagan A, Murphy SN, Ananthakrishnan AN, Liao KP.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2242-2246. doi: 10.1093/ibd/izy127.

44.

The role of diet in the aetiopathogenesis of inflammatory bowel disease.

Khalili H, Chan SSM, Lochhead P, Ananthakrishnan AN, Hart AR, Chan AT.

Nat Rev Gastroenterol Hepatol. 2018 Sep;15(9):525-535. doi: 10.1038/s41575-018-0022-9. Review.

45.

IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.

Simon TG, Van Der Sloot KWJ, Chin SB, Joshi AD, Lochhead P, Ananthakrishnan AN, Xavier R, Chung RT, Khalili H.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2247-2257. doi: 10.1093/ibd/izy128.

46.

Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients.

Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN.

J Crohns Colitis. 2018 May 12. doi: 10.1093/ecco-jcc/jjy064. [Epub ahead of print]

47.

Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.

Burke KE, Khalili H, Garber JJ, Haritunians T, McGovern DPB, Xavier RJ, Ananthakrishnan AN.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1840-1848. doi: 10.1093/ibd/izy083.

48.

Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases.

Ananthakrishnan AN, Martin C, Kane S, Sandler RS, Long MD.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):203-204. doi: 10.1016/j.cgh.2018.04.001. Epub 2018 Apr 11.

PMID:
29653290
49.

Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.

Luther J, Gala M, Patel SJ, Dave M, Borren N, Xavier RJ, Ananthakrishnan AN.

Dig Dis Sci. 2018 Mar;63(3):738-745. doi: 10.1007/s10620-018-4932-8. Epub 2018 Jan 25.

50.

Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women.

Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

J Crohns Colitis. 2018 Apr 27;12(5):559-567. doi: 10.1093/ecco-jcc/jjy005.

Supplemental Content

Loading ...
Support Center